immatics biotechnologies GmbH (4A3) — Working Capital to Net Assets Ratio
immatics biotechnologies GmbH (4A3) has a Working Capital to Net Assets ratio of 95.2% as of December 2025. Working capital of €461.00 Million (current assets of €504.01 Million minus current liabilities of €43.01 Million) is measured against net assets of €484.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 4A3 equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
immatics biotechnologies GmbH Working Capital to Net Assets (2019–2025)
This chart shows how immatics biotechnologies GmbH's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the ratio stands at 95.2%, reflecting working capital of €461.00 Million against net assets of €484.10 Million EUR. Check immatics biotechnologies GmbH tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for immatics biotechnologies GmbH (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for immatics biotechnologies GmbH from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 4A3 company net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 95.2% | €461.00 Million | €484.10 Million | €504.01 Million | €43.01 Million | ▼ -2.5 pp |
| 2024 | 97.7% | €561.57 Million | €574.84 Million | €629.55 Million | €67.99 Million | ▼ -32.4 pp |
| 2023 | 130.1% | €292.82 Million | €225.08 Million | €449.37 Million | €156.55 Million | ▲ +3.1 pp |
| 2022 | 127.0% | €270.70 Million | €213.16 Million | €377.15 Million | €106.45 Million | ▼ -110.1 pp |
| 2021 | 237.1% | €57.06 Million | €24.06 Million | €152.21 Million | €95.15 Million | ▲ +82.2 pp |
| 2020 | 154.9% | €161.51 Million | €104.26 Million | €238.99 Million | €77.48 Million | ▲ +288.9 pp |
| 2019 | -134.0% | €54.70 Million | €-40.84 Million | €124.00 Million | €69.30 Million | — |